Silencing Metabolic Disorders by Novel SIRT1 Activators
Research output: Contribution to journal › Letter › Research › peer-review
Standard
Silencing Metabolic Disorders by Novel SIRT1 Activators. / Sakamoto, Kei.
In: Cell Metabolism, Vol. 7, No. 1, 09.01.2008, p. 3-4.Research output: Contribution to journal › Letter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Silencing Metabolic Disorders by Novel SIRT1 Activators
AU - Sakamoto, Kei
PY - 2008/1/9
Y1 - 2008/1/9
N2 - SIRT1, a NAD+-dependent protein deacetylase that regulates transcription factors involved in key cellular processes, has been implicated as a mediator of the beneficial effects of calorie restriction. In a recent issue of Nature, Milne et al. (2007) describe novel potent activators of SIRT1, whose administration to insulin-resistant animals improves glucose homeostasis.
AB - SIRT1, a NAD+-dependent protein deacetylase that regulates transcription factors involved in key cellular processes, has been implicated as a mediator of the beneficial effects of calorie restriction. In a recent issue of Nature, Milne et al. (2007) describe novel potent activators of SIRT1, whose administration to insulin-resistant animals improves glucose homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=37449033325&partnerID=8YFLogxK
U2 - 10.1016/j.cmet.2007.12.005
DO - 10.1016/j.cmet.2007.12.005
M3 - Letter
C2 - 18177718
AN - SCOPUS:37449033325
VL - 7
SP - 3
EP - 4
JO - Cell Metabolism
JF - Cell Metabolism
SN - 1550-4131
IS - 1
ER -
ID: 239583846